NewLink Genetics (NLNK) Tops Q1 EPS Expectations

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to NewLink Genetics (NLNK) Tops Q1 EPS Expectations

NewLink Genetics Corporation Provides Operational Update and Reports First Quarter 2015 Financial Results

May 5, 2015 7:01 AM EDT

AMES, Iowa, May 5, 2015 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (Nasdaq: NLNK), a biopharmaceutical company focused on bringing novel immuno-oncology medicines to patients with cancer, today reported consolidated financial results for the first quarter of 2015 and progress in its clinical and business development programs.

"NewLink Genetics continued to execute on its immuno-oncology pipeline of products during the first quarter," said Dr. Charles Link, Chairman and Chief Executive Officer. "On the IDO/TDO front, we have successfully launched both our small molecule research and clinical development teams with Genentech, and we are excited about the... More